Atezolizumab for the treatment of non-small cell lung cancer.
Santini, Fernando C
Atezolizumab for the treatment of non-small cell lung cancer. [electronic resource] - Expert review of clinical pharmacology Sep 2017 - 935-945 p. digital
Publication Type: Journal Article; Review
1751-2441
10.1080/17512433.2017.1356717 doi
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
Humans
Immunohistochemistry
Immunotherapy--methods
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoplasm Staging
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Atezolizumab for the treatment of non-small cell lung cancer. [electronic resource] - Expert review of clinical pharmacology Sep 2017 - 935-945 p. digital
Publication Type: Journal Article; Review
1751-2441
10.1080/17512433.2017.1356717 doi
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--administration & dosage
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
Humans
Immunohistochemistry
Immunotherapy--methods
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoplasm Staging
Programmed Cell Death 1 Receptor--antagonists & inhibitors